Lv52
940 积分 2025-09-16 加入
Transition of Blood Biomarkers During 24-Week Treatment With Lebrikizumab or Tralokinumab in Atopic Dermatitis: A Real-World Analysis Stratified by Prior Systemic Therapy
3天前
已完结
Transition of Blood Biomarkers During 24-Week Treatment With Lebrikizumab or Tralokinumab in Atopic Dermatitis: A Real-World Analysis Stratified by Prior Systemic Therapy
4天前
已关闭
Transition of Blood Biomarkers During 24-Week Treatment With Lebrikizumab or Tralokinumab in Atopic Dermatitis: A Real-World Analysis Stratified by Prior Systemic Therapy
5天前
已完结
Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28-Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
5天前
已完结
Single-centre experience with tralokinumab in dupilumab-experienced and naïve patients with atopic dermatitis
5天前
已完结
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series
5天前
已完结
Transition of Blood Biomarkers During 24-Week Treatment With Lebrikizumab or Tralokinumab in Atopic Dermatitis: A Real-World Analysis Stratified by Prior Systemic Therapy
5天前
已完结
Real-world experience of tralokinumab for atopic dermatitis in adults and adolescents: A 16-week multicenter retrospective study
5天前
已完结
Rational Design of High‐Entropy Garnet Electrolytes via Computational Screening for Stable Lithium Interfaces in All‐Solid‐State Batteries
18天前
已完结
Real-world experience of tralokinumab for atopic dermatitis in adults and adolescents: A 16-week multicenter retrospective study
19天前
已完结
皖公网安备34019202002308
